Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Hansson L, et al. Among authors: rahn kh. Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6. Lancet. 1998. PMID: 9635947 Clinical Trial.
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. Zanchetti A, et al. Among authors: rahn kh. J Hypertens. 1998 Jul;16(7):949-61. doi: 10.1097/00004872-199816070-00008. J Hypertens. 1998. PMID: 9794735 Clinical Trial.
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators. Zanchetti A, et al. Among authors: rahn kh. Circulation. 2002 Nov 5;106(19):2422-7. doi: 10.1161/01.cir.0000039288.86470.dd. Circulation. 2002. PMID: 12417537 Clinical Trial.
ESH-ESC guidelines for the management of hypertension.
Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B. Erdine S, et al. Among authors: rahn kh. Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3. Herz. 2006. PMID: 16810473 Free article.
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.
Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Lüscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A; ESH/ESC Hypertension Guidelines Committee. Cifkova R, et al. Among authors: rahn kh. J Hypertens. 2003 Oct;21(10):1779-86. doi: 10.1097/01.hjh.0000084773.37215.1b. J Hypertens. 2003. PMID: 14508180 No abstract available.
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire.
Olsen MH, Mallion JM, Rahn KH, Erdine S, Viigimaa M, Laurent S, Agabiti-Rosei E, Mancia G, Schmieder RE, Cifkova R, Dominiczak A, Kjeldsen SE, Redon J, Zanchetti A, Nilsson P, Narkiewicz K; ESH Council. Olsen MH, et al. Among authors: rahn kh. J Hypertens. 2010 Jul;28(7):1593-4. doi: 10.1097/HJH.0b013e32833b7b08. J Hypertens. 2010. PMID: 20574253 No abstract available.
262 results